NewsBenzingaBMO Capital mantiene su recomendación de “rendimiento de mercado” sobre Bath & Body Works y reduce el precio objetivo a 20 dólares. BMO Capital mantiene su recomendación de “rendimiento de mercado” sobre Bath & Body Works y reduce el precio objetivo a 20 dólares. Benzinga 2026.11.20 16:25 (GMT+0) Open on Benzinga Other news AI Stocks' Wild Ride Gets Bumpier As Nvidia Chaos, Blue Tsunami Spook Investors Stock Market Dives To New Lows Despite Nvidia Earnings, Anthropic IPO: Weekly Review Could Jensen Huang Land At Nvidia Rival Intel? BMO Capital Maintains Market Perform on BILL Holdings, Lowers Price Target to $63.25 Merck Reports Positive Survival Data For Investigational Therapy for Advanced Gastric Cancer BMO Capital Maintains Market Perform on Bath & Body Works, Lowers Price Target to $20